Wednesday, June 13, 2012

The Aging Brain: What's New in Brain Research, Treatment, and Policy

By: Todd E. Feinberg M.D.

As researchers home in on biomarkers for the progress of dementia, how should treatment and policy change? A webcast of the inaugural event in the Neuroscience and Society Series, presented by the AAAS and the Dana Foundation.

As researchers home in on biomarkers for the progress of dementia, how should treatment and policy change? A webcast of the inaugural event in the Neuroscience and Society Series, presented by the AAAS and the Dana Foundation.



About Cerebrum

Bill Glovin, editor
Carolyn Asbury, Ph.D., consultant

Scientific Advisory Board
Joseph T. Coyle, M.D., Harvard Medical School
Kay Redfield Jamison, Ph.D., The Johns Hopkins University School of Medicine
Pierre J. Magistretti, M.D., Ph.D., University of Lausanne Medical School and Hospital
Robert Malenka, M.D., Ph.D., Stanford University School of Medicine
Bruce S. McEwen, Ph.D., The Rockefeller University
Donald Price, M.D., The Johns Hopkins University School of Medicine

Do you have a comment or question about something you've read in CerebrumContact Cerebrum Now.